June
In-depth Coverage

Sites rate Novo Nordisk, Roche, Amgen on top
A new CenterWatch survey of global investigative sites shows sponsors overall have improved their relationships with investigative sites during the past three years, as pharmaceutical companies increasingly focus on strategies to improve site quality and performance.

India and China: the reality behind the hype
Are India and China—two emerging markets widely heralded as the hottest growth areas for clinical trials—really living up to the hype? A few years ago, analysts predicted a massive shift in clinical trials from the developed world into emerging markets. But instead of a rush, it has been more of a trickle.

Eye On Bayer HealthCare
A detailed examination of Bayer HealthCare Pharmaceuticals' drug discovery pipeline.

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Featured Jobs

May
In-depth Coverage

Sites worldwide rate top CROs
A new CenterWatch survey of investigative sites around the world shows CROs have continued to improve their relationships with sites. Three global CROs came out with top rankings: PPD, Kendle and ICON.

Step-up in FDA audits has sites scrambling to be ready
Sites used to rely on monitors to ensure their compliance. But now, with the FDA ramping up scrutiny and protocols growing more complex, sites must be responsible for their own quality assurance and always be audit-ready.

Eye On Human Genome Sciences
A detailed examination at HGS’s drug discovery pipeline.

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.